Purchase Articles
Showing 113–128 of 157 resultsSorted by latest
-
HTA decisions and access to mental health treatments in Canada’s public drug plans
Read Article -
The fiscal burden of provincial government health spending across Canada
Read Article -
Hospital spending across Canada’s Provinces, 1990-2014
Read Article -
Costs without benefits for patients? Non-medical spending in Canada’s public health system
Read Article -
Les gouvernements pourraient économiser 5 milliards de dollars par année
Read Article -
Cost of physicians across Canada: 2016 Report
Read Article -
How long do new patented medicines have market exclusivity in Canada’s public drug plans?
Read Article -
Governments could save $5 billion annually by allowing user charges for physician services in Canada
Read Article -
Economic evaluations in health technology assessments: what more can be done?
Read Article -
Pan-Canadian Pharmaceutical Alliance: another hurdle for Canadian patients to access new drugs?
Read Article -
Spending on patented drugs in Canada 1990 to 2014.
Read Article -
Coverage for new medicines in public versus private drug plans in Canada.
Read Article -
Fewer treatment options for patients if Canada adopts New Zealand’s prescription drug policies.
Read Article -
Economic cost of delayed access to 14 new cancer medicines in Canada’s public drug plans.
Read Article -
Including off-label drug indications in HTA jeopardizes patient health and discourages innovation
Read Article -
Medical Resource Availability in Canada and 34 OECD countries: 2016 Annual Report
Read Article